|
Market Closed -
NYSE
01:30:00 20/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.9528 USD | -2.61% |
|
-0.14% | -42.95% |
| 01/10 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
Tradegate
| BT3 | Real-time | |
Deutsche Boerse AG
| BT3 | Delayed | |
Börse Stuttgart
| BT3 | Delayed | |
Boerse Muenchen
| BT3 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.09 | 1.14 | 1.35 |
| Spread/Res. | -12.59% | -16.42% | -29.42% |
| Spread/Supp. | +5.37% | +5.37% | +2.42% |
| Support | 0.9042 | 0.9042 | 0.9303 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















